GLP‐1 receptor agonists vs. DPP‐4 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other?
Crossref DOI link: https://doi.org/10.1111/ijcp.12361
Published Online: 2014-02-06
Published Print: 2014-05
Update policy: https://doi.org/10.1002/crossmark_policy
Brunton, S.
Version of Record valid from 2014-02-06
Text and Data Mining valid from 2014-02-06
Text and Data Mining valid from 2015-09-01
Publication History